DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Fluorouracil (Fluorouracil) - Adverse Event Reports - Hospitalization

 



Index of reports > Cases resulting in hospitalization (334)

     Vomiting (34)Diarrhoea (31)Abdominal Pain (26)Pyrexia (25)Dehydration (25)Neutropenia (22)Asthenia (21)Nausea (20)Sepsis (18)Dyspnoea (17)

Below is the selection of adverse event reports related to Fluorouracil that includes cases resulting in hospitalization.

 Reports 1 - 25 of 334   Next >>

Adverse event in 77 year old male receiving Fluorouracil

Reported by a physician from Germany on 2007-10-31

Patient: 77 year old male

Adverse reactions / side effects: Nephrotic Syndrome, Renal Failure Acute

Adverse event resulted in: hospitalization

Suspect drug(s):
Erbitux
    Indication: Colon Cancer
    Start date: 2006-08-10
    End date: 2007-02-13

Fluorouracil
    Dosage: no.of dosage=d1+d2
    Indication: Colon Cancer
    Start date: 2005-07-19
    End date: 2007-02-13

Irinotecan HCL
    Indication: Colon Cancer
    Start date: 2005-07-19
    End date: 2007-02-13

Leucovorin
    Dosage: no.of dosage=d1+d2
    Indication: Colon Cancer
    Start date: 2005-07-19
    End date: 2007-02-13

Other drugs received by patient: Penmix



Adverse event in male receiving Fluorouracil

Reported by a individual with unspecified qualification from United States on 2007-10-31

Patient: male, weighing 69.1 kg (152.0 pounds)

Adverse reactions / side effects: Fatigue, Vomiting, Nausea, Rectal Tenesmus, Proctalgia

Adverse event resulted in: hospitalization

Suspect drug(s):
Bevacizumab(rhumab Vegf)
    Dosage: 1130 mg
    End date: 2007-09-11

Eloxatin
    Dosage: 479 mg
    End date: 2007-09-11

Fluorouracil
    Dosage: 12632 mg
    End date: 2007-09-11

Leucovorin Calcium
    Dosage: 2256 mg
    End date: 2007-09-11



Adverse event in male receiving Fluorouracil

Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-31

Patient: male, weighing 100.9 kg (222.0 pounds)

Adverse reactions / side effects: Oral Intake Reduced, Clostridium Difficile Colitis

Adverse event resulted in: hospitalization

Suspect drug(s):
Cisplatin
    Dosage: 150mg iv
    Indication: Neoplasm Malignant
    Start date: 2007-08-23

Fluorouracil
    Dosage: 1500mg bid iv qd
    Indication: Neoplasm Malignant
    Start date: 2007-08-23
    End date: 2007-08-27

Taxotere
    Dosage: 150mg iv
    Indication: Neoplasm Malignant
    Start date: 2007-08-23

Other drugs received by patient: Ambien; Aspirin; Ativan; Compazine; Hyzaar; Lidex; Lipitor; Loprox; Nasonex; Singulair; Zofran



Adverse event in male receiving Fluorouracil

Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-31

Patient: male, weighing 100.9 kg (222.0 pounds)

Adverse reactions / side effects: Syncope Vasovagal, Arteriospasm Coronary, Cardiac Disorder

Adverse event resulted in: hospitalization

Suspect drug(s):
Cisplatin
    Dosage: 150mg iv
    Indication: Neoplasm Malignant
    Start date: 2007-08-23

Fluorouracil
    Dosage: 1500mg bid iv qd
    Indication: Neoplasm Malignant
    Start date: 2007-08-23
    End date: 2007-08-27

Taxotere
    Dosage: 150mg iv
    Indication: Neoplasm Malignant
    Start date: 2007-08-23

Other drugs received by patient: Ambien; Aspirin; Ativan; Compazine; Hyzaar; Lidex; Lipitor; Loprox; Nasonex; Singulair; Zofran



Adverse event in female receiving Fluorouracil

Reported by a consumer/non-health professional from United Kingdom on 2007-10-31

Patient: female, weighing 61.5 kg (135.3 pounds)

Adverse reactions / side effects: Vomiting, Diarrhoea, Hypokalaemia

Adverse event resulted in: hospitalization

Suspect drug(s):
Bevacizumab
    Dosage: 326 mg, q2w
    Indication: Colon Cancer
    Start date: 2007-04-04

Fluorouracil
    Dosage: 650 mg, q2w
    Start date: 2007-04-04

Leucovorin
    Dosage: 320 mg, q2w
    Indication: Colon Cancer
    Start date: 2007-04-04

Oxaliplatin
    Dosage: 137 mg, q2w
    Indication: Colon Cancer
    Start date: 2007-04-04

Other drugs received by patient: Rabeprazole Sodium; Zofran; Prochlorperazine; Aluminum Hydroxide Gel; Norvasc; Bisoprolol Fumarate; Ramipril



Adverse event in female receiving Fluorouracil

Reported by a physician from Egypt on 2007-10-30

Patient: female, weighing 65.0 kg (143.0 pounds)

Adverse reactions / side effects: Pneumonia, Pancytopenia

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Fluorouracil
    Dosage: 400 mg/m2 bolus followed by 600 mg/m2 infusion
    Start date: 2006-12-18
    End date: 2006-12-19

Leucovorin
    Start date: 2006-12-18
    End date: 2006-12-19

Oxaliplatin
    Indication: Colon Cancer
    Start date: 2006-12-18
    End date: 2006-12-18



Adverse event in female receiving Fluorouracil

Reported by a individual with unspecified qualification from United States on 2007-10-29

Patient: female, weighing 52.7 kg (115.9 pounds)

Adverse reactions / side effects: Oral Intake Reduced, Intestinal Obstruction, Thirst

Adverse event resulted in: hospitalization

Suspect drug(s):
Bevacizumab (Rhumab Vegf)
    Dosage: 264 mg
    End date: 2007-10-10

Eloxatin
    Dosage: 128 mg
    End date: 2007-10-10

Fluorouracil
    Dosage: 4200 mg
    End date: 2007-10-12

Leucovorin Calcium
    Dosage: 600 mg
    End date: 2007-10-10



Adverse event in male receiving Fluorouracil

Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-29

Patient: male, weighing 175.0 kg (385.0 pounds)

Adverse reactions / side effects: Hepatic Failure, Disease Progression

Adverse event resulted in: hospitalization

Suspect drug(s):
Aranesp
    Dosage: 200 a?g, prn
    Indication: Anaemia

Avastin
    Dosage: 590 mg, unk
    Indication: Metastatic Neoplasm
    Start date: 2005-07-18
    End date: 2005-08-02

Fluorouracil
    Dosage: 1140 mg, unk
    Indication: Metastatic Neoplasm
    Start date: 2005-07-18
    End date: 2005-07-20

Fluorouracil
    Dosage: 760 mg, unk
    Start date: 2005-08-02
    End date: 2005-08-03

Fluorouracil
    Dosage: 1140 mg, unk
    Start date: 2005-08-02
    End date: 2005-08-04

Leucovorin
    Dosage: 380 mg, unk
    Indication: Metastatic Neoplasm
    Start date: 2005-07-18
    End date: 2005-08-03

Oxaliplatin
    Dosage: 160 mg, unk
    Indication: Metastatic Neoplasm
    Start date: 2005-07-18
    End date: 2005-08-02



Adverse event in male receiving Fluorouracil

Reported by a individual with unspecified qualification from United States on 2007-10-29

Patient: male, weighing 79.1 kg (174.0 pounds)

Adverse reactions / side effects: Type IV Hypersensitivity Reaction

Adverse event resulted in: hospitalization

Suspect drug(s):
Bevacizumab (Rhumab Vegf)
    Dosage: 387 mg
    End date: 2007-10-24

Eloxatin
    Dosage: 47 mg
    End date: 2007-10-24

Fluorouracil
    Dosage: 5180 mg
    End date: 2007-10-24

Leucovorin Calcium
    Dosage: 740 mg
    End date: 2007-10-24



Adverse event in male receiving Fluorouracil

Reported by a physician from Germany on 2007-10-26

Patient: male

Adverse reactions / side effects: Hepatic Function Abnormal, Diarrhoea, Sepsis, Dehydration, Gastrointestinal Inflammation, Circulatory Collapse, Bronchitis

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Eloxatin
    Indication: Gastric Cancer
    Start date: 2007-08-01
    End date: 2007-08-01

Fluorouracil
    Indication: Gastric Cancer
    Start date: 2007-08-01
    End date: 2007-08-01

Folinic Acid
    Indication: Gastric Cancer
    Start date: 2007-08-01
    End date: 2007-08-01

Other drugs received by patient: Fumaderm; Novalgin; Nexium



Adverse event in male receiving Fluorouracil

Reported by a consumer/non-health professional from United Kingdom on 2007-10-26

Patient: male

Adverse reactions / side effects: Pancytopenia, Septic Shock

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Avastin
    Dosage: 275 mg, unk
    Indication: Colorectal Cancer
    Start date: 2006-07-10
    End date: 2006-07-10

Camptosar
    Dosage: 300 mg, unk
    Indication: Colorectal Cancer
    Start date: 2006-07-10
    End date: 2006-07-10

Fluorouracil
    Dosage: 4600 mg, unk
    Indication: Colorectal Cancer
    Start date: 2006-07-10
    End date: 2006-07-10

Folinic Acid
    Indication: Drug USE FOR Unknown Indication
    Start date: 2006-07-10
    End date: 2006-07-10



Adverse event in female receiving Fluorouracil

Reported by a physician from United Kingdom on 2007-10-25

Patient: female, weighing 137.8 kg (303.2 pounds)

Adverse reactions / side effects: Abdominal Pain, Vomiting, Pyrexia

Adverse event resulted in: hospitalization

Suspect drug(s):
Bevacizumab
    Dosage: 312.5 mg, q2w
    Indication: Colon Cancer
    Start date: 2007-04-23

Fluorouracil
    Dosage: 660 mg, q2w
    Indication: Colon Cancer
    Start date: 2007-04-23

Leucovorin
    Dosage: 660 mg, q2w
    Indication: Colon Cancer
    Start date: 2007-04-23

Oxaliplatin
    Dosage: 140 mg, q2w
    Indication: Colon Cancer
    Start date: 2007-04-23

Other drugs received by patient: Neupogen; Modulon; Iron Supplement



Adverse event in female receiving Fluorouracil

Reported by a individual with unspecified qualification from United States on 2007-10-24

Patient: female, weighing 54.0 kg (118.8 pounds)

Adverse reactions / side effects: Febrile Neutropenia

Adverse event resulted in: hospitalization

Suspect drug(s):
Cisplatin
    Dosage: 68 mg

Ellence
    Dosage: 42 mg

Erbitux
    Dosage: 1125 mg

Fluorouracil
    Dosage: 6300 mg



Adverse event in male receiving Fluorouracil

Reported by a individual with unspecified qualification from United States on 2007-10-24

Patient: male, weighing 69.1 kg (152.0 pounds)

Adverse reactions / side effects: Fatigue, Vomiting, Nausea, Proctalgia

Adverse event resulted in: hospitalization

Suspect drug(s):
Bevacizumab (Rhumab Vegf)
    Dosage: 1130 mg
    End date: 2007-09-11

Eloxatin
    Dosage: 479 mg
    End date: 2007-09-11

Fluorouracil
    Dosage: 12632 mg
    End date: 2007-09-11

Leucovorin Calcium
    Dosage: 2256 mg
    End date: 2007-09-11



Adverse event in female receiving Fluorouracil

Reported by a physician from United States on 2007-10-24

Patient: female

Adverse reactions / side effects: Asthenia

Adverse event resulted in: hospitalization

Suspect drug(s):
Fluorouracil

Irinotecan HCL

Leucovorin

Panitumumab
    Indication: Colorectal Cancer
    Start date: 2007-07-26

Panitumumab
    Start date: 2007-08-14
    End date: 2007-08-14

Other drugs received by patient: Synthroid; Wellbutrin



Adverse event in male receiving Fluorouracil

Reported by a individual with unspecified qualification from United States on 2007-10-24

Patient: male, weighing 27.9 kg (61.4 pounds)

Adverse reactions / side effects: Cholecystitis Acute, Enterobacter Sepsis

Adverse event resulted in: hospitalization

Suspect drug(s):
Fluorouracil
    Indication: Metastatic Neoplasm
    Start date: 2007-08-07
    End date: 2007-08-19

Fluorouracil

Irinotecan HCL
    Indication: Metastatic Neoplasm

Leucovorin
    Indication: Metastatic Neoplasm

Sutent
    Dosage: daily dose:25mg-freq:1 daily
    Administration route: Oral
    Indication: Metastatic Neoplasm
    Start date: 2007-08-08
    End date: 2007-08-20



Adverse event in male receiving Fluorouracil

Reported by a physician from United States on 2007-10-23

Patient: male

Adverse reactions / side effects: Dehydration, Sepsis, Paraneoplastic Syndrome

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Bevacizumab
    Indication: Colorectal Cancer Metastatic
    Start date: 2007-07-09
    End date: 2007-07-09

Eloxatin
    Dosage: 65 mg/m2 (131.3 mg) every 2 weeks
    Indication: Colorectal Cancer Metastatic
    Start date: 2007-07-09
    End date: 2007-07-09

Fluorouracil
    Dosage: 606 mg bolus (300 mg/m2); 3636 mg (1800 mg/m2) every 2 weeks
    Indication: Colorectal Cancer Metastatic
    Start date: 2007-07-11
    End date: 2007-07-11

Leucovorin
    Dosage: 800 mg (400 mg/m2) every 2 weeks
    Indication: Colorectal Cancer Metastatic
    Start date: 2007-07-09
    End date: 2007-07-09

Other drugs received by patient: Multi-Vitamin; Lipitor; Digitek; Pepcid; Cardizem; Cozaar; Coumadin; Megace; Nystatin



Adverse event in female receiving Fluorouracil

Reported by a physician from United States on 2007-10-23

Patient: female

Adverse reactions / side effects: Acute Myocardial Infarction

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Fluorouracil

Irinotecan HCL

Leucovorin

Panitumumab
    Indication: Colorectal Cancer
    Start date: 2007-09-13



Adverse event in male receiving Fluorouracil

Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-23

Patient: male, weighing 175.0 kg (385.0 pounds)

Adverse reactions / side effects: Abdominal Pain, Jaundice, Metastatic Neoplasm, Bile Duct Obstruction, Malignant Neoplasm Progression, Hepatic Failure, Oedema Peripheral, Abdominal Distension, Decreased Appetite, Lethargy

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Aranesp
    Indication: Anaemia

Avastin
    Indication: Metastatic Neoplasm
    Start date: 2005-08-02
    End date: 2005-08-02

Avastin
    Dosage: unk

Fluorouracil
    Indication: Metastatic Neoplasm
    Start date: 2005-08-02
    End date: 2005-08-04

Leucovorin
    Indication: Metastatic Neoplasm
    Start date: 2005-08-02
    End date: 2005-08-03

Oxaliplatin
    Indication: Metastatic Neoplasm
    Start date: 2005-08-02
    End date: 2005-08-02



Adverse event in male receiving Fluorouracil

Reported by a health professional (non-physician/pharmacist) from France on 2007-10-23

Patient: male

Adverse reactions / side effects: Chest Pain, Gait Disturbance, Cerebellar Syndrome

Adverse event resulted in: hospitalization

Suspect drug(s):
Duragesic-100
    Indication: Drug USE FOR Unknown Indication

Eloxatin
    Indication: Colon Cancer
    Start date: 2007-07-01
    End date: 2007-07-01

Eloxatin
    Start date: 2007-07-25
    End date: 2007-07-25

Fluorouracil
    Indication: Colon Cancer
    Start date: 2007-07-01
    End date: 2007-07-01

Fluorouracil
    Start date: 2007-07-25
    End date: 2007-07-25

Fluorouracil
    Start date: 2007-08-07
    End date: 2007-08-07

Forlax
    Dosage: unk
    Administration route: Oral

Lederfoline
    Indication: Colon Cancer
    Start date: 2007-07-01
    End date: 2007-07-01

Lederfoline
    Start date: 2007-07-25
    End date: 2007-07-25

Lederfoline
    Start date: 2007-08-07
    End date: 2007-08-07

Lexomil
    Administration route: Oral

Paroxetine
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication

Zofran
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication

Other drugs received by patient: Cosopt; Xalatan



Adverse event in female receiving Fluorouracil

Reported by a individual with unspecified qualification from United States on 2007-10-22

Patient: female, weighing 97.7 kg (214.9 pounds)

Adverse reactions / side effects: Urinary Incontinence, Encephalopathy, Headache, Pyrexia, Convulsion, Tremor, Depressed Level of Consciousness, Asthenia

Adverse event resulted in: hospitalization

Suspect drug(s):
Bevacizumab (Rhumab Vegf)
    Dosage: 973 mg
    End date: 2007-07-24

Eloxatin
    Dosage: 266 mg
    End date: 2007-07-24

Fluorouracil
    Dosage: 9160 mg
    End date: 2007-07-24

Leucovorin Calcium
    Dosage: 1636 mg
    End date: 2007-07-24



Adverse event in female receiving Fluorouracil

Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-19

Patient: female, weighing 57.6 kg (126.7 pounds)

Adverse reactions / side effects: Abdominal Pain, Empty Sella Syndrome, Diarrhoea, Septic Shock, Cerebrovascular Accident

Adverse event resulted in: hospitalization

Suspect drug(s):
Fluorouracil
    Indication: Colorectal Cancer

Leucovorin
    Indication: Colorectal Cancer

Oxaliplatin
    Indication: Colorectal Cancer
    Start date: 2007-07-25
    End date: 2007-07-25

Other drugs received by patient: Lipitor; Hydrochlorothiazide; Xanax



Adverse event in female receiving Fluorouracil

Reported by a consumer/non-health professional from United Kingdom on 2007-10-19

Patient: female, weighing 61.5 kg (135.3 pounds)

Adverse reactions / side effects: Vomiting, Blood Potassium Decreased, Diarrhoea

Adverse event resulted in: hospitalization

Suspect drug(s):
Bevacizumab
    Dosage: 326 mg, q2w
    Indication: Colon Cancer
    Start date: 2007-04-04

Fluorouracil
    Dosage: 650 mg, q2w
    Start date: 2007-04-04

Leucovorin
    Dosage: 320 mg, q2w
    Indication: Colon Cancer
    Start date: 2007-04-04

Oxaliplatin
    Dosage: 137 mg, q2w
    Indication: Colon Cancer
    Start date: 2007-04-04

Other drugs received by patient: Rabeprazole Sodium; Zofran; Prochlorperazine; Aluminum Hydroxide Gel; Norvasc; Bisoprolol Fumarate; Ramipril



Adverse event in 46 year old male receiving Fluorouracil

Reported by a health professional (non-physician/pharmacist) on 2007-10-19

Patient: 46 year old male

Adverse reactions / side effects: Stomatitis, Folliculitis, Febrile Neutropenia, Hypokalaemia

Adverse event resulted in: hospitalization

Suspect drug(s):
Cisplatin
    Start date: 2007-06-04
    End date: 2007-06-04

Fluorouracil
    Dosage: dose: 75 for 5 days (day 1 to day 5)
    Start date: 2007-06-04
    End date: 2007-06-09

Taxotere
    Start date: 2007-06-04
    End date: 2007-06-04



Adverse event in female receiving Fluorouracil

Reported by a individual with unspecified qualification from United States on 2007-10-19

Patient: female, weighing 76.7 kg (168.7 pounds)

Adverse reactions / side effects: Abdominal Pain, Fatigue, Vomiting, Diarrhoea, Nausea, Anorexia, Dizziness, Neutropenia

Adverse event resulted in: hospitalization

Suspect drug(s):
Bevacizumab (Rhumab Vegf)
    Dosage: 380 mg
    End date: 2007-10-04

Eloxatin
    Dosage: 308 mg
    End date: 2007-10-04

Fluorouracil
    Dosage: 1448 mg
    End date: 2007-10-04

Leucovorin Calcium
    Dosage: 1448 mg
    End date: 2007-10-04



 Page 1   Next >>

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009